We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.47%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.5B
AUM Growth
-$885M
(-4.1%)
Cap. Flow
+$1.02B
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
26.63%
Holding
880
New
29
Increased
471
Reduced
285
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
B
Barrick Mining
B
|
+$221M |
| 2 |
Newmont
NEM
|
+$187M |
| 3 |
Franco-Nevada
FNV
|
+$168M |
| 4 |
GG
Goldcorp Inc
GG
|
+$134M |
| 5 |
Agnico Eagle Mines
AEM
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$254M |
| 2 |
SLB Ltd
SLB
|
+$70.2M |
| 3 |
RSPP
RSP Permian, Inc.
RSPP
|
+$67.5M |
| 4 |
Halliburton
HAL
|
+$55.3M |
| 5 |
JD.com
JD
|
+$43.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 48.2% |
| 2 | Energy | 15.4% |
| 3 | Technology | 7.34% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Staples | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Qiagen
QGEN
$8.53B
| $17M | 0.08% |
423,189
+6,284
| +2% | +$251K |
|
|
DO
202
DELISTED
Diamond Offshore Drilling
DO
| $16.9M | 0.08% |
846,895
-431,626
| -34% | -$7.93M |
|
203
Oil States International
OIS
$514M
| $16.4M | 0.08% |
492,873
-215,532
| -30% | -$7.04M |
|
204
Walmart Inc
WMT
$886B
| $15.6M | 0.08% |
496,821
+119,037
| +32% | +$3.64M |
|
205
Sociedad Química y Minera de Chile
SQM
$19.6B
| $15.2M | 0.07% |
332,825
+3,113
| +0.9% | +$143K |
|
|
CJ
206
DELISTED
C&J Energy Services, Inc.
CJ
| $15.1M | 0.07% |
727,641
-272,597
| -27% | -$6.11M |
|
|
SLCA
207
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $15M | 0.07% |
795,648
-487,595
| -38% | -$11.3M |
|
208
Neurocrine Biosciences
NBIX
$17.7B
| $14.9M | 0.07% |
121,594
-1,948
| -2% | -$221K |
|
|
DCUD
209
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $14.6M | 0.07% |
308,682
+21,427
| +7% | +$1.02M |
|
|
CCT
210
DELISTED
Corporate Capital Trust, Inc.
CCT
| $14.3M | 0.07% |
934,935
+58,258
| +7% | +$957K |
|
211
Perrigo
PRGO
$1.43B
| $14.2M | 0.07% |
200,744
-8,046
| -4% | -$604K |
|
212
Qorvo
QRVO
$7.83B
| $14.1M | 0.07% |
183,969
-20,659
| -10% | -$1.65M |
|
213
AstraZeneca
AZN
$263B
| $14.1M | 0.07% |
177,919
-12,792
| -7% | -$968K |
|
214
Sanofi
SNY
$106B
| $13.9M | 0.07% |
311,091
-50,104
| -14% | -$2.14M |
|
215
GSK
GSK
$105B
| $13.8M | 0.07% |
274,038
-705
| -0.3% | -$35.8K |
|
216
Novartis
NVS
$297B
| $13.8M | 0.07% |
178,215
-28,986
| -14% | -$2.14M |
|
217
Nektar Therapeutics
NKTR
$2.37B
| $13.6M | 0.07% |
14,848
+2,404
| +19% | +$2.05M |
|
218
ON Semiconductor
ON
$33.7B
| $13.5M | 0.07% |
735,125
-191,559
| -21% | -$4.09M |
|
219
Toro Company
TTC
$9.01B
| $13.5M | 0.07% |
224,669
-11,348
| -5% | -$690K |
|
220
Bausch Health
BHC
$1.71B
| $13.2M | 0.06% |
515,480
+20,894
| +4% | +$478K |
|
|
NVO
221
Novo Nordisk
NVO
$219B
| $13M | 0.06% |
550,650
-45,458
| -8% | -$1.11M |
|
222
Lowe's Companies
LOW
$119B
| $12.9M | 0.06% |
111,999
-194,644
| -63% | -$20.3M |
|
|
GPL
223
DELISTED
Great Panther Mining Limited
GPL
| $12.8M | 0.06% |
1,511,465
+135,471
| +10% | +$1.34M |
|
224
FS KKR Capital
FSK
$3.04B
| $12.7M | 0.06% |
451,001
+29,017
| +7% | +$887K |
|
225
Charles River Laboratories
CRL
$10.8B
| $12.7M | 0.06% |
94,157
+481
| +0.5% | +$59.4K |
|
Similar funds
DAM
VanEck Associates's Q3 2018 Portfolio in Review
As of Q3 2018, VanEck Associates held 880 positions worth $20.5B, down 4.1% from $21.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
VanEck Associates deployed $1.02B of net new capital in Q3 2018, opening 29 new positions and adding to 471 existing holdings. Its largest new stake was ChampionX: 882,077 shares worth $38.4M.
By sector, the portfolio is most concentrated in Materials at 48% of assets, down from 51% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Kirkland Lake Gold Ltd Ordinary, an estimated $254M trimmed.
- VanEck Associates's largest Q3 2018 buy was ChampionX: 882,077 shares worth $38.4M.
- VanEck Associates added most to Barrick Mining in Q3 2018, an estimated $221M increase.
- VanEck Associates's biggest Q3 2018 reduction was Kirkland Lake Gold Ltd Ordinary, cutting an estimated $254M.
- VanEck Associates fully exited RSP Permian, Inc. in Q3 2018, selling an estimated $67.5M.
- VanEck Associates's ten largest holdings make up 27% of its $20.5B portfolio in Q3 2018.
- VanEck Associates opened 29 new positions and closed 89 in Q3 2018.
- VanEck Associates's portfolio value fell 4.1% quarter-over-quarter to $20.5B.
Based on VanEck Associates's 13F filing for Q3 2018, filed 13 Nov 2018.